{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:28:18Z","timestamp":1787016498349,"version":"build-2736575974"},"reference-count":54,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"476","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA164574"],"award-info":[{"award-number":["R01CA164574"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA215093"],"award-info":[{"award-number":["R01CA215093"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016056"],"award-info":[{"award-number":["P30CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2019,1,23]]},"abstract":"<jats:p>HER2 remains a therapeutic target in drug-resistant HER2-positive breast cancer, and a recombinant human protein overcomes the drug resistance.<\/jats:p>","DOI":"10.1126\/scitranslmed.aav1620","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T19:10:25Z","timestamp":1548270625000},"source":"Crossref","is-referenced-by-count":25,"title":["A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer"],"prefix":"10.1126","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2532-8638","authenticated-orcid":true,"given":"Lu","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA."},{"name":"Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arup","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0976-2875","authenticated-orcid":true,"given":"Yuesheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA."},{"name":"Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-011-1132-8"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1370"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.1.103"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3798106"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052122"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.3.719"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113216"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/0008-5472.473.65.2","article-title":"Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line","volume":"65","author":"Nagy P.","year":"2005","unstructured":"P. Nagy, E. Friedlander, M. Tanner, A. I. Kapanen, K. L. Carraway, J. Isola, T. M. Jovin, Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line. Cancer Res. 65, 473\u2013482 (2005).","journal-title":"Cancer Res."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk134"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.85"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2309"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.03.039"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1014835108"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/74704"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.8957"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.00.661"},{"key":"e_1_3_2_18_2","first-page":"8887","article-title":"Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2\/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo","volume":"61","author":"Moulder S. L.","year":"2001","unstructured":"S. L. Moulder, F. M. Yakes, S. K. Muthuswamy, R. Bianco, J. F. Simpson, C. L. Arteaga, Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2\/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. Cancer Res. 61, 8887\u20138895 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.03.016"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9851"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.187"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.055"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2003.32"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64952-8"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006146"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1535-7163.1585.3.12","article-title":"Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer","volume":"3","author":"Tanner M.","year":"2004","unstructured":"M. Tanner, A. I. Kapanen, T. Junttila, O. Raheem, S. Grenman, J. Elo, K. Elenius, J. Isola, Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer. Mol. Cancer Ther. 3, 1585\u20131592 (2004).","journal-title":"Mol. Cancer Ther."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-1171"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1204503"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090885"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-2911-z"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867311320190008"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5962"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3067"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7409"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01392"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.234"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3504"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02097-9"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0970"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-4-7"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(04)00083-2"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7261"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4597"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.4130"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00510-5"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80157-4"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0380"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712169105"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.532"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0550-04.2004"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-013-1019-4"},{"key":"e_1_3_2_52_2","first-page":"128","article-title":"Cancer and thrombosis","volume":"24","author":"Donati M. B.","year":"1994","unstructured":"M. B. Donati, Cancer and thrombosis. Haemostasis 24, 128\u2013131 (1994).","journal-title":"Haemostasis"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70349-X"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.429159"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M412767200"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1126\/scitranslmed.aav1620","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.aav1620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T13:45:08Z","timestamp":1705412708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.aav1620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":54,"journal-issue":{"issue":"476","published-print":{"date-parts":[[2019,1,23]]}},"alternative-id":["10.1126\/scitranslmed.aav1620"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.aav1620","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"article-number":"eaav1620"}}